|
**Overview**: Iron Studies Monitoring Panel**Introduction**: The Iron Studies Monitoring Panel is a diagnostic tool designed to monitor iron metabolism using serum samples. In India, serial monitoring is essential in iron deficiency anemia treatment (oral/IV iron), thalassemia major (chelation), or chronic disease anemia, with ferritin guiding therapy duration and overload prevention. High morbidity from inadequate monitoring in rural/low-SES patients on iron therapy or thalassemia, limited labs, delayed adjustment leading to persistent anemia or iron toxicity. Per hematology practices aligned with ICMR and National Thalassemia Control Programme guidelines, the test employs spectrophotometry for serum iron, TIBC, ferritin, and transferrin saturation over 1-2 days with high accuracy, valuable for assessing response and safety. This diagnostic falls under anemia monitoring and targets patients on iron/chelation therapy or with chronic anemia, addressing accurate detection to guide dose modification and prevent complications. With elevated morbidity due to under-monitoring, the test supports public health efforts by enabling precise iron status tracking and reducing anemia burden. Its serum-based approach ensures reliable longitudinal assessment.**Other Names**: Iron Monitor Pnl.**FDA Status**: FDA approved, CLIA certified for biochemistry/hematology, compliant with 2025 standards.**Historical Milestone**: Iron monitoring standard; in India, key in thalassemia programs.**Purpose**: The test assesses 4 parameters including serum iron to guide iron metabolism monitoring, evaluate treatment response, inform adjustment.**Test Parameters**: 1. Serum Iron, 2. TIBC, 3. Ferritin, 4. Transferrin Saturation.**Pretest Condition**: Fasting 10-12 hours recommended; patients should be on iron/chelation therapy.**Specimen**: 3 mL serum in 1 SST, transported within specified times to maintain sample viability.**Sample Stability at Room Temperature**: 8 hours with proper handling to preserve analyte integrity, ensuring reliable test performance.**Sample Stability at Refrigeration**: 7 days at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate testing is preferred.**Sample Stability at Frozen**: 6 months at -20 degrees Celsius, allowing long-term storage for retesting, though freezing may affect some analytes.**Medical History**: Patients should provide details on therapy type, duration, symptoms.**Consent**: Written informed consent is required, detailing the test's purpose, potential risks of improper iron levels including toxicity/anemia, benefits of monitoring, and minimal discomfort from venipuncture.**Procedural Considerations**: The test involves sample processing using spectrophotometry by trained personnel to ensure sterile technique, avoid hemolysis, and interpret results within 1-2 days using provided controls. Laboratories must maintain a controlled environment, adhere to quality assurance protocols.**Factors Affecting Result Accuracy**: Delays beyond stability periods, improper storage conditions, hemolysis, or recent iron intake can affect results. Correlation with clinical evaluation or additional testing is recommended to confirm findings.**Clinical Significance**: Rising ferritin indicates response/overload; low saturation suggests ongoing deficiency, necessitating specialist input.**Specialist Consultation**: Hematologists should be consulted for management.**Additional Supporting Tests**: CBC, liver function for confirmation.**Test Limitations**: Ferritin acute-phase; comprehensive approach required.**References**: Indian Journal of Hematology 2024, Anemia Studies India 2023. |
